Candace Lovejoy

1.0k total citations · 1 hit paper
8 papers, 737 citations indexed

About

Candace Lovejoy is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Candace Lovejoy has authored 8 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Candace Lovejoy's work include Viral Infections and Outbreaks Research (3 papers), RNA Interference and Gene Delivery (2 papers) and Viral gastroenteritis research and epidemiology (2 papers). Candace Lovejoy is often cited by papers focused on Viral Infections and Outbreaks Research (3 papers), RNA Interference and Gene Delivery (2 papers) and Viral gastroenteritis research and epidemiology (2 papers). Candace Lovejoy collaborates with scholars based in United States. Candace Lovejoy's co-authors include Dennis E. Hruby, Douglas W. Grosenbach, Jarasvech Chinsangaram, Biswajit Maiti, Kady M. Honeychurch, Eric A. Rose, Patrick L. Iversen, Hong M. Moulton, Andrew T. Russo and Michelle H. Nelson and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Candace Lovejoy

8 papers receiving 713 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Tecovirimat for the Treatment of Smallpox

2018 274 citations Douglas W. Grosenbach, Kady M. Honeychurch et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Candace Lovejoy

Since Specialization

Citations

This map shows the geographic impact of Candace Lovejoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace Lovejoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace Lovejoy more than expected).

Fields of papers citing papers by Candace Lovejoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candace Lovejoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace Lovejoy. The network helps show where Candace Lovejoy may publish in the future.

Co-authorship network of co-authors of Candace Lovejoy

This figure shows the co-authorship network connecting the top 25 collaborators of Candace Lovejoy. A scholar is included among the top collaborators of Candace Lovejoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace Lovejoy. Candace Lovejoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications 2020 ·Expert Review of Anti-infective Therapy ·Andrew T. Russo, Douglas W. Grosenbach, Jarasvech Chinsangaram, Kady M. Honeychurch, (unknown), Candace Lovejoy, Biswajit Maiti, (unknown), Dennis E. Hruby	143
2	Oral Tecovirimat for the Treatment of Smallpox breakdown → 2018 ·New England Journal of Medicine ·Douglas W. Grosenbach, Kady M. Honeychurch, Eric A. Rose, Jarasvech Chinsangaram, (unknown), Biswajit Maiti, Candace Lovejoy, (unknown), (unknown), Dennis E. Hruby	274
3	Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase 2013 ·Antimicrobial Agents and Chemotherapy ·Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu, Dongcheng Dai, Kevin F. Jones, (unknown), Christine A. Schneider, Guang Yang, Shanthakumar Tyavanagimatt, (unknown), (unknown), Jessica Pagé, Eric Stavale, (unknown), (unknown), Candace Lovejoy, Janet M. Leeds, Dennis E. Hruby, Robert Jordan	82
4	SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activity 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Jordan Boutilier, (unknown), Dima Gharaibeh, Candace Lovejoy, Sean M. Amberg, Dennis E. Hruby, Shanthakumar Tyavanagimatt, Robert D. Allen, Dongcheng Dai	38
5	Treatment of highly pathogenic filovirus infections using advanced antisense technology 2010 ·Retrovirology ·Travis K. Warren, Kelly L. Warfield, Jay Wells, Dana L. Swenson, Candace Lovejoy, Patrick L. Iversen, Sina Bavari	2
6	Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo 2009 ·Journal of Antimicrobial Chemotherapy ·Brett L. Mellbye, Dwight D. Weller, (unknown), (unknown), Candace Lovejoy, Patrick L. Iversen, Bruce L. Geller	42
7	Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection 2009 ·Antimicrobial Agents and Chemotherapy ·Dana L. Swenson, Kelly L. Warfield, Travis K. Warren, Candace Lovejoy, (unknown), Gordon Ruthel, Robert Blouch, Hong M. Moulton, Dwight D. Weller, Patrick L. Iversen, Sina Bavari	53
8	Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity 2007 ·Nucleic Acids Research ·Rebecca P. Wu, (unknown), (unknown), Candace Lovejoy, Michelle H. Nelson, Patrick L. Iversen, Hong M. Moulton	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact